Immunotherapy in Older Adults: A Checkpoint to Palliation?

Elias, Rawad; Odejide, Oreofe

Elias, Rawad; Odejide, Oreofe.

Affiliation

Elias R; 1 Hartford HealthCare Cancer Institute, Hartford Hospital, Hartford, CT.
Odejide O; 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Am Soc Clin Oncol Educ Book ; 39: e110-e120, 2019 Jan.

Article in En | MEDLINE | ID: mdl-31099630

Subject(s)

Immunotherapy; Neoplasms/therapy; Age Factors; Aged; Antineoplastic Agents, Immunological/administration & dosage; Antineoplastic Agents, Immunological/adverse effects; Antineoplastic Agents, Immunological/therapeutic use; Biomarkers, Tumor; Body Composition; Disease Management; Humans; Immunomodulation/drug effects; Immunotherapy/adverse effects; Immunotherapy/methods; Neoplasms/diagnosis; Neoplasms/immunology; Palliative Care; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Am Soc Clin Oncol Educ Book Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google